(Q80156074)

English

Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines

scientific article published on 09 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Humoral immunity targeting site I of antigenic domain 2 of glycoprotein B upon immunization with different cytomegalovirus candidate vaccines (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Fredrika Axelsson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Stuart P Adler

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alain Lamarre

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

9 November 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

41-46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Modification of maternal and congenital cytomegalovirus infection by anti-glycoprotein b antibody transfer in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

The outcome of congenital cytomegalovirus infection in relation to maternal antibody status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Passive Immunization during Pregnancy for Congenital Cytomegalovirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Is there a formula for an effective CMV vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Prevention and treatment of cytomegalovirus pneumonia in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Human cytomegalovirus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Antigenic domain 1 of human cytomegalovirus glycoprotein B induces a multitude of different antibodies which, when combined, results in incomplete virus neutralization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Recognition of human cytomegalovirus by human primary immunoglobulins identifies an innate foundation to an adaptive immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

The gp116 of the gp58/116 complex of human cytomegalovirus represents the amino-terminal part of the precursor molecule and contains a neutralizing epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Intragenic variability of human cytomegalovirus glycoprotein B in clinical strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Glycoprotein gp116 of human cytomegalovirus contains epitopes for strain-common and strain-specific antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

An ELISA using recombinant proteins for the detection of neutralizing antibodies against human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Mucosal antibodies to human cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Light chain shuffling of a high affinity antibody results in a drift in epitope recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

A divalent antibody format is required for neutralization of human cytomegalovirus via antigenic domain 2 on glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Binding characteristics determine the neutralizing potential of antibody fragments specific for antigenic domain 2 on glycoprotein B of human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Human monoclonal antibodies neutralizing human cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.048

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.10.048

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18063447%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80156074&oldid=1508351359"